Enhanced left ventricular performance with phentolamine in acute myocardial infarction. 1974

P Walinsky, and K Chatterjee, and J Forrester, and W W Parmley, and H J Swan

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010646 Phentolamine A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease. Fentolamin,Phentolamine Mesilate,Phentolamine Mesylate,Phentolamine Methanesulfonate,Phentolamine Mono-hydrochloride,Regitine,Regityn,Rogitine,Z-Max,Mesilate, Phentolamine,Mesylate, Phentolamine,Methanesulfonate, Phentolamine,Mono-hydrochloride, Phentolamine,Phentolamine Mono hydrochloride
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females

Related Publications

P Walinsky, and K Chatterjee, and J Forrester, and W W Parmley, and H J Swan
January 1971, Progress in cardiovascular diseases,
P Walinsky, and K Chatterjee, and J Forrester, and W W Parmley, and H J Swan
April 1973, Circulation,
P Walinsky, and K Chatterjee, and J Forrester, and W W Parmley, and H J Swan
June 1975, British heart journal,
P Walinsky, and K Chatterjee, and J Forrester, and W W Parmley, and H J Swan
October 1970, Circulation,
P Walinsky, and K Chatterjee, and J Forrester, and W W Parmley, and H J Swan
December 1974, The American journal of cardiology,
P Walinsky, and K Chatterjee, and J Forrester, and W W Parmley, and H J Swan
March 1976, British heart journal,
P Walinsky, and K Chatterjee, and J Forrester, and W W Parmley, and H J Swan
March 1971, The Journal of clinical investigation,
P Walinsky, and K Chatterjee, and J Forrester, and W W Parmley, and H J Swan
May 1970, The American journal of cardiology,
P Walinsky, and K Chatterjee, and J Forrester, and W W Parmley, and H J Swan
July 1968, Lancet (London, England),
P Walinsky, and K Chatterjee, and J Forrester, and W W Parmley, and H J Swan
November 1996, European heart journal,
Copied contents to your clipboard!